Pomalidomide domestic price

Pomalidomide is available in the United States in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have disease progression on or within 60 days of completion of the last therapy. and for use in patients with AIDS-related Kaposi's sarcoma after failure of highly active antiretroviral therapy (HAART) or in patients with HIV-negative Kaposi's sarcoma. Pomalidomide candirectly inhibit angiogenesis and myeloma cell growth. This dual action is central to its activity in myeloma, rather than other pathways such as TNFα inhibition, because potent TNF inhibitors including rolipram and pentoxifylline do not inhibit myeloma cell growth or angiogenesis.

Pomalidomide, independently developed in China, has been launched in the country and has now entered the scope of medical insurance. The price of each box of domestically produced pomalidomide may be around RMB 4,000. The reimbursement conditions apply to patients who meet the indications. The price per box may be around RMB 4,000. Different regions have different reimbursement ratios and reimbursement prices. The price of each box of the Turkish version listed overseas may be around 15,000 yuan (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.